Yadlapati Ajay, Sweis Ranya, Schimmel Daniel
Interventional Cardiology, Northwestern University Feinberg School of Medicine, Division of Cardiology, 676 N. St. Clair Street, Suite 600, Chicago, IL 60611-2996 USA.
J Invasive Cardiol. 2016 Mar;28(3):E30-3.
We describe a case series of 3 patients presenting with intracardiac thrombi treated with standard anticoagulation therapy and intervention with ultrasound-accelerated thrombolysis therapy. Right-sided intracardiac thrombi portend significant mortality due to their susceptibility for embolization and pulmonary embolus despite the continuation of current standard of therapy of parenteral anticoagulation and surgical embolectomy if warranted. We demonstrate the safety and clinical efficacy of ultrasound-accelerated thrombolysis therapy with the EkoSonic Endovascular System infusion catheter system (EKOS Corporation) and highlight its use in resolving intracardiac thrombi and impeding the propagation of pulmonary emboli.
我们描述了一组3例患有心内血栓的患者,他们接受了标准抗凝治疗,并采用超声加速溶栓疗法进行干预。尽管目前采用肠外抗凝和必要时进行手术取栓的标准治疗方法,但右侧心内血栓因其易发生栓塞和肺栓塞而预示着较高的死亡率。我们展示了使用EkoSonic血管内系统输注导管系统(EKOS公司)进行超声加速溶栓治疗的安全性和临床疗效,并强调了其在解决心内血栓和阻止肺栓塞扩散方面的应用。